GE VernovavsKewaunee Scientific

GEV and KEQU stock compared: price, dividend, valuation and results, from SEC filings.

GEV

GE Vernova Inc.

$781.00

Value $211B

+1.14%
GEV's page

KEQU

Kewaunee Scientific Corporation

$33.26

Value $95M

-4.04%
KEQU's page

GE Vernova (GEV) has a market value of $211B and Kewaunee Scientific (KEQU) $95M. Over the last year, with dividends, GEV moved +41.1% and KEQU -15.7%. The P/E is 20.3 for GEV and 11.6 for KEQU. Dividend yield: GEV 0.26%, KEQU none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    GEV$211B

    KEQU$95M

    GEV is 2,205 times KEQU

  • Revenue, 12 months

    GEV$44.0B

    KEQU$277M

    GEV is 159 times KEQU

  • Net income, 12 months

    GEV$10.4B

    KEQU$8.2M

    GEV is 1,260 times KEQU

  • Operating margin

    GEV6.4%

    KEQU5.4%

    1.0 points apart

  • ROIC

    GEV19.5%

    KEQU11.4%

    8.1 points apart

  • P/E

    GEV20.3

    KEQU11.6

    GEV is 1.8 times KEQU

  • Dividend yield

    GEV0.3%

    KEQU0.0%

    0.3 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

GEV+41.1%

KEQU-15.7%

100150200DecFebAprJunAugOct
Returns by period
PeriodGEVWith dividendsKEQUWith dividends
1 year since November 18, 2025+41.1%Price +40.7%-15.7%Price -15.7%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

GEVGE VernovaKEQUKewaunee Scientific

Valuation

GEVKEQU
Valuation
Price$781.00$33.26
Market value$211B$95M
Enterprise value (EV)$197B–
P/E20.311.6
P/E, 5-year median–9.9
P/B18.51.3
EV/EBIT69.5–
Free cash flow yield8.1%11.4%

Results and growth

GEVKEQU
Results and growth
Revenue, 12 months$44.0B$277M
Net income, 12 months$10.4B$8.2M
Free cash flow, 12 months$17.1B$11M
Earnings per share, 12 months$38.00$2.76
Revenue growth, year on year9.0%17.3%
Revenue growth a year, past+8.7%over 3 years+13.8%over 5 years
EPS growth a year, past––

Margins and returns on capital

GEVKEQU
Margins and returns on capital
Gross margin21.7%28.5%
Operating margin6.4%5.4%
Net margin23.5%3.0%
ROIC19.5%11.4%
ROE90.8%11.5%

Balance sheet

GEVKEQU
Balance sheet
Cash$16.8B$8.2M
Total debt$3.7B–
Net debt / EBITDA-4.1–
Interest cover–3.5×

Dividends and buybacks

GEVKEQU
Dividends and buybacks
Dividend yield0.3%–
Dividend per share, 12 months$2.00–
Dividend growth a year, past––
Buyback yield1.6%–
Shareholder yield1.8%–

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: GEV or KEQU

Didn't find what you were looking for?

Ask us
Which is bigger, GE Vernova or Kewaunee Scientific?

By market value, GE Vernova ($211B) is about 2,204.9 times Kewaunee Scientific ($95M), at today's prices.

How did GEV and KEQU stock do over the last 1 years?

Since November 18, 2025, GEV's price moved +40.7% and KEQU's -15.7%. With dividends: GEV +41.1% (+41.1% a year), KEQU -15.7% (-15.7% a year). Past returns do not predict future ones.

Which pays the higher dividend, GEV or KEQU?

The dividend yield at today's price is 0.26% for GE Vernova and none for Kewaunee Scientific. Over the last twelve months they paid $2.00 and – per share.

What is the P/E of GEV and KEQU?

At today's price, the P/E is 20.3 for GEV and 11.6 for KEQU. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, GE Vernova or Kewaunee Scientific?

Over the last twelve months, the net margin was 23.5% for GE Vernova and 3.0% for Kewaunee Scientific, and the operating margin 6.4% and 5.4%. Revenue was $44.0B and $277M.

Which is the better investment, GE Vernova or Kewaunee Scientific?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.